TipRanks
Go Ultimate55% OFF

Ginkgo Bioworks Holdings (DNA) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

DNA Analyst Ratings

Moderate Sell
3Ratings
0Buy1Hold2Sell
Based on 3 analysts giving stock ratings to Ginkgo Bioworks Holdings in the past 3 months

DNA Stock 12 Month Forecast

MXN 149.30▲(27.61% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Ginkgo Bioworks Holdings in the last 3 months. The average price target is MXN 149.30 with a high forecast of MXN 205.29 and a low forecast of MXN 93.31. The average price target represents a 27.61% change from the last price of MXN 117.00.
Highest Price TargetMXN 205.29Average Price TargetMXN 149.30Lowest Price TargetMXN 93.31

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:DNA
Price TargetFollowArticle
TD CowenMXN 167.96→MXN 205.29hold75.46%UpsideReiterated10/13/26
BTIGMXN 93.31sell-20.25%DownsideReiterated09/04/26
William Blair―sell―Reiterated08/13/26
Bank of America Securities Analyst forecast on MX:DNAUnknown AnalystNot RankedBank of America Securities―sell―Reiterated11/07/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ginkgo Bioworks Holdings

3 Months
Success Rate9/22 ratings generated profit
41%
Average Return
-8.68%

Copying Mark Massaro's trades and holding each position for 3 Months would result in 40.91% of your transactions generating a profit, with an average return of -8.68% per trade.

1 Year
Success Rate5/22 ratings generated profit
23%
Average Return
-22.42%

Copying Mark Massaro's trades and holding each position for 1 Year would result in 22.73% of your transactions generating a profit, with an average return of -22.42% per trade.

2 Years
Success Rate4/22 ratings generated profit
18%
Average Return
-36.53%

Copying Mark Massaro's trades and holding each position for 2 Years would result in 18.18% of your transactions generating a profit, with an average return of -36.53% per trade.

DNA Analyst Recommendation Trends

02468Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for DNA
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy11000
Hold00112
Sell11233
Strong Sell00000
total22345

In the current month, DNA has received 0 Buy Ratings, 2 Hold Ratings, and 3 Sell Ratings. DNA average Analyst price target in the past 3 months is 149.30.

DNA Financial Forecast

MXN -29MXN -24MXN -19MXN -14MXN -9Q4 2025Q2 2026Q3 2026
HighMXN -9.40
ConsensusMXN -12.74
LowMXN -16.09

DNA Earnings Forecast

Next quarter’s earnings estimate for DNA is -MXN 12.74 with a range of -MXN 16.09 to -MXN 9.40. The previous quarter’s EPS was -MXN 14.09. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

MXN 366MMXN 456.9MMXN 547.9MMXN 638.9MMXN 729.8MQ4 2025Q2 2026Q3 2026
HighMXN 432M
ConsensusMXN 404M
LowMXN 385M

DNA Sales Forecast

Next quarter’s sales forecast for DNA is MXN 404.03M with a range of MXN 385.24M to MXN 432.22M. The previous quarter’s sales results were MXN 378.77M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

DNA Stock Forecast FAQ

What is MX:DNA’s average 12-month price target, according to analysts?
Based on analyst ratings, Ginkgo Bioworks Holdings’s 12-month average price target is Mex$149.30.
What is MX:DNA’s upside potential, based on the analysts’ average price target?
Ginkgo Bioworks Holdings has 27.61% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Ginkgo Bioworks Holdings a Buy, Sell or Hold?
Ginkgo Bioworks Holdings has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 1 hold ratings and 2 sell ratings.
What is Ginkgo Bioworks Holdings’s share price target?
The average share price target for Ginkgo Bioworks Holdings is Mex$149.30. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$205.29, and the lowest forecast is Mex$93.31. The average share price target represents a 27.61% increase from the current price of Mex$117.
What do analysts say about Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Ginkgo Bioworks Holdings?
To buy shares of MX:DNA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.